Literature DB >> 7143013

Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.

D Schmidt, W Löscher.   

Abstract

In 49 patients with various neurological disorders plasma and CSF gamma-aminobutyric acid (GABA) concentrations were determined by radioreceptor assay. The CSF GABA concentration of 127 +/- 47 pmol/ml (range: 65-275; n = 52) was independent of the age, the sex and the intake of various drugs including benzodiazepines, baclofen and antidepressants. Patients with diverse neurological disorders such as multiple sclerosis, ischaemic strokes, intracranial tumour and polyneuropathies had similar CSF GABA levels. The mean plasma GABA concentration was 309 +/- 79 pmol/ml (range: 179-498; n = 44). The correlation between the GABA concentrations of CSF and plasma was very poor (r = 0.18; n = 44). Therefore plasma GABA is not a suitable indicator for CSF GABA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143013      PMCID: PMC491600          DOI: 10.1136/jnnp.45.10.931

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.

Authors:  B S Glaeser; W H Vogel; D B Oleweiler; T A Hare
Journal:  Biochem Med       Date:  1975-04

2.  Measurement of GABA in human cerebrospinal fluid.

Authors:  B S Glaeser; T A Hare
Journal:  Biochem Med       Date:  1975-03

3.  Letter: Gamma-aminobutyric acid in CSF in schizophrenia.

Authors:  D H Langer; G L Brown; W E Bunney; D P van Kammen
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

4.  Identification of GABA in human CSF by gas liquid chromatography and mass spectrometry.

Authors:  J D Huizinga; A W Teelken; F A Muskiet; J vd Meulen; B G Wolthers
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

5.  Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.

Authors:  T L Perry; S Hansen; M Kloster
Journal:  N Engl J Med       Date:  1973-02-15       Impact factor: 91.245

6.  Verification and quantification of GABA in human cerebrospinal fluid.

Authors:  J H Wood; B S Glaeser; S J Enna; T A Hare
Journal:  J Neurochem       Date:  1978-01       Impact factor: 5.372

7.  gamma-Aminobutyric acid (GABA) in human cerebrospinal fluid: radioreceptor assay.

Authors:  S J Enna; J H Wood; S H Snyder
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

8.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.

Authors:  S J Enna; L Z Stern; G J Wastek; H I Yamamura
Journal:  Arch Neurol       Date:  1977-11

10.  Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.

Authors:  V S Achar; K M Welch; E Chabi; K Bartosh; J S Meyer
Journal:  Neurology       Date:  1976-08       Impact factor: 9.910

View more
  9 in total

1.  Metabolite concentration changes associated with positive and negative BOLD responses in the human visual cortex: A functional MRS study at 7 Tesla.

Authors:  Yohan Boillat; Lijing Xin; Wietske van der Zwaag; Rolf Gruetter
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-12       Impact factor: 6.200

Review 2.  Dogs as a Natural Animal Model of Epilepsy.

Authors:  Wolfgang Löscher
Journal:  Front Vet Sci       Date:  2022-06-22

3.  Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.

Authors:  Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Shunyan Mo; Hien P Nguyen; Abby Svenson; Nina Jaitly; Janet E Hall; Bruce A Barton; Anthony J Rothschild; Scott A Shaffer
Journal:  Psychoneuroendocrinology       Date:  2016-05-09       Impact factor: 4.905

4.  Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis.

Authors:  D Rating; H Siemes; W Löscher
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

5.  Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.

Authors:  P P Roy-Byrne; D S Cowley; D Hommer; D J Greenblatt; G L Kramer; F Petty
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders.

Authors:  Helen V Ratajczak; Robert B Sothern
Journal:  Future Sci OA       Date:  2015-11-01

Review 7.  Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.

Authors:  Roni Manyevitch; Matthew Protas; Sean Scarpiello; Marisa Deliso; Brittany Bass; Anthony Nanajian; Matthew Chang; Stefani M Thompson; Neil Khoury; Rachel Gonnella; Margit Trotz; D Blaine Moore; Emily Harms; George Perry; Lucy Clunes; Angelica Ortiz; Jan O Friedrich; Ian V J Murray
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 8.  Neurovascular Unit as a Source of Ischemic Stroke Biomarkers-Limitations of Experimental Studies and Perspectives for Clinical Application.

Authors:  Aleksandra Steliga; Przemysław Kowiański; Ewelina Czuba; Monika Waśkow; Janusz Moryś; Grażyna Lietzau
Journal:  Transl Stroke Res       Date:  2019-11-07       Impact factor: 6.800

9.  Quantification of aminobutyric acids and their clinical applications as biomarkers for osteoporosis.

Authors:  Zhiying Wang; Liangqiao Bian; Chenglin Mo; Hui Shen; Lan Juan Zhao; Kuan-Jui Su; Maciej Kukula; Jauh Tzuoh Lee; Daniel W Armstrong; Robert Recker; Joan Lappe; Lynda F Bonewald; Hong-Wen Deng; Marco Brotto
Journal:  Commun Biol       Date:  2020-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.